Confirma Inc. this week unveiled three promotions

TriMed Staff | | Health Imaging | Artificial Intelligence
Dan Bickford has been elevated to vice president of sales and marketing. Prior to Confirma, Bickford served in senior sales and marketing positions with NexCura Inc., ESC Medical Systems and Neopath (now Tripath).

 Chris Wood has become vice president of research and development. Wood previously held various senior management positions with the former Picker International Inc. and Siemens Medical Solutions USA Inc. He has been involved with product development for the post-processing of medical images in CT, nuclear medicine, ultrasound and magnetic resonance imaging.

 Mary Gatewood has been promoted to director of marketing. Gatewood previously held marketing positions at the former Pointshare (now Siemens Medical Solutions) and Ostex International.

TriMed Staff

Related Content

New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA
PHOTO GALLERY: Medical imaging technology at RSNA 2024
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
New algorithm is twice as accurate at predicting stroke timing compared to the standard of care

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.